These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 6465015)

  • 21. Antiarrhythmic efficacy of ethmozine in patients with ventricular tachycardia as determined by programmed electrical stimulation.
    Miura DS; Wynn J; Torres V; Laux B; Keefe D; Somberg JC
    Am Heart J; 1986 Apr; 111(4):661-6. PubMed ID: 3513503
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative efficacy of pirmenol and procainamide in a drug-resistant population with ventricular tachycardia.
    Miura DS; Schwartz J; Laux B; Wynn J; Keefe D; Somberg JC
    J Clin Pharmacol; 1987 Jul; 27(7):481-6. PubMed ID: 3654999
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term lorcainide therapy in patients with ventricular tachycardia.
    Somberg J; Butler B; Flowers D; Keefe D; Torres V; Miura D
    Am Heart J; 1985 Jan; 109(1):33-40. PubMed ID: 3966330
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of incremental doses of procainamide in patients with sustained uniform ventricular tachycardia.
    Grimm W; Cho JG; Marchlinski FE
    J Cardiovasc Electrophysiol; 1994 Apr; 5(4):313-22. PubMed ID: 8019707
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Availability of electrophysiological approach to the selection and assessment of antiarrhythmic drugs for recurrent ventricular tachycardia.
    Kasanuki H; Ohnishi S; Hirosawa K
    Jpn Circ J; 1983 Jan; 47(1):105-23. PubMed ID: 6827769
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Procainamide in the induction and perpetuation of ventricular tachycardia in man.
    Kang PS; Gomes JA; El-Sherif N
    Pacing Clin Electrophysiol; 1982 May; 5(3):311-22. PubMed ID: 6179048
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Simultaneous appearance of endocardial late potentials and ability to induce sustained ventricular tachycardia after procainamide administration.
    Gallagher JD; Fernandez J; Maranhao V; Gessman LJ
    J Electrocardiol; 1986 Apr; 19(2):197-201. PubMed ID: 3486933
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antiarrhythmic and hemodynamic evaluation of indecainide and procainamide in nonsustained ventricular tachycardia.
    Pratt CM; Francis MJ; Seals AA; Zoghbi W; Young JB
    Am J Cardiol; 1990 Jul; 66(1):68-74. PubMed ID: 2193498
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Verapamil in ventricular tachycardia.
    Hasin Y; Kriwisky M; Gotsman MS
    Cardiology; 1984; 71(4):199-206. PubMed ID: 6478466
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lorcainide therapy in a cardiac arrest population.
    Somberg JC; Laux B; Wynn J; Keefe D; Miura DS
    Am Heart J; 1986 Apr; 111(4):648-53. PubMed ID: 3953387
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enhanced efficacy of oral sotalol for sustained ventricular tachycardia refractory to type I antiarrhythmic drugs.
    Kienzle MG; Martins JB; Wendt DJ; Constantin L; Hopson R; McCue ML
    Am J Cardiol; 1988 May; 61(13):1012-7. PubMed ID: 3129926
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of procainamide on induced ventricular tachycardia.
    Engel TR; del Gonzalez A; Meister SG; Franki WS
    Clin Pharmacol Ther; 1978 Sep; 24(3):274-82. PubMed ID: 688720
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pacing termination of ventricular tachycardia: influence of antiarrhythmic-slowed ectopic rate.
    Keren G; Miura DS; Somberg JC
    Am Heart J; 1984 Apr; 107(4):638-43. PubMed ID: 6702556
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long term lorcainide therapy guided by electrophysiology studies.
    Somberg J; Butler B; Flowers D; Tepper D; Torres V
    Acta Cardiol; 1985; 40(6):621-36. PubMed ID: 3879419
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Electrophysiologic assessment of antiarrhythmic drug efficacy for ventricular tachyarrhythmias associated with dilated cardiomyopathy.
    Rae AP; Spielman SR; Kutalek SP; Kay HR; Horowitz LN
    Am J Cardiol; 1987 Feb; 59(4):291-5. PubMed ID: 3544793
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antiarrhythmic drug therapy for sustained ventricular tachycardia.
    Kienzle MG; Williams PD; Zygmont D; Doherty JU; Josephson ME
    Heart Lung; 1984 Nov; 13(6):614-22. PubMed ID: 6149202
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Factors predisposing to postural hypotensive symptoms in the treatment of high blood pressure.
    Talbot S; Smith AJ
    Br Heart J; 1975 Oct; 37(10):1059-63. PubMed ID: 127594
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Electrophysiologic mechanism of exercise-induced sustained ventricular tachycardia.
    Sung RJ; Shen EN; Morady F; Scheinman MM; Hess D; Botvinick EH
    Am J Cardiol; 1983 Feb; 51(3):525-30. PubMed ID: 6823868
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relationship between plasma levels of procainamide, suppression of premature ventricular complexes and prevention of recurrent ventricular tachycardia.
    Myerburg RJ; Kessler KM; Kiem I; Pefkaros KC; Conde CA; Cooper D; Castellanos A
    Circulation; 1981 Aug; 64(2):280-90. PubMed ID: 7249296
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of the characteristics of nonsustained ventricular tachycardia on Holter monitoring and sustained ventricular tachycardia observed spontaneously or induced by programmed stimulation.
    Kim SG; Mercando AD; Fisher JD
    Am J Cardiol; 1987 Aug; 60(4):288-92. PubMed ID: 3618487
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.